2026 William Corbett Award

| 31 March 2026

We are pleased to announce that Dr. Nicholas Phillipow is the recipient of the 2026 William Corbett Award. This award is a testament of Nicholas’ diagnostic excellence and academic achievement during his studies within the Department of Pathology and Molecular Medicine.

Congratulations Nicholas!!

ACADEMIC GYNECOLOGIC PATHOLOGIST

Jobs

| 31 March 2026

Academic Gynecologic Pathologist, Pathology & Molecular Medicine

Queen’s Health Sciences

Position Overview

The Division of Anatomic Pathology within the Department of Pathology & Molecular Medicine at Queen’s University at Kingston invites applications for a Clinical Academic Gynecologic Pathologist appointment. The successful candidate will play a key role in advancing clinical care and academic/scholarly service in the field of pathology. This position is to fill an existing vacancy within the University.

We are a regional referral centre with over 37 000 surgical pathology cases a year and a strong integrated clinical genomics program. Our practice is fully subspecialized; pathologists generally participate in one or two subspecialty service areas. We are a very collegial department with a strong culture of scholarship. The Department supports the academic development of clinical faculty through allocated academic time, access to research infrastructure and/or teaching development opportunities, consistent with the expectations of clinical academic appointments.

The successful incumbent will be expected to dedicate approximately 70% of their effort to clinical duties and 30% to academic responsibilities. The academic component will be divided between education, research and administration, tailored to align with both departmental priorities and the candidate’s individual interests. The successful incumbent will provide evidence of an ability to work in an interdisciplinary, collaborative environment. Applicants should demonstrate strong potential for outstanding teaching contributions in the department’s undergraduate, graduate, and residency training programs. We will further prioritize a track record of and potential for improving the practice of pathology through research, education, quality improvement, or clinical innovation.

Qualified applicants will hold an MD degree (or equivalent) and be eligible for licensure by the College of Physicians and Surgeons of Ontario. Certification, or eligibility for certification, by the Royal College of Physicians and Surgeons of Canada in Anatomical Pathology is preferred. Candidates must demonstrate training and experience in gynecologic pathology. The ability to participate in another diagnostic pathology subspecialty would be valued.

Why Queen’s

Queen’s University is recognized nationally for the quality of its undergraduate and graduate programs, which attracts outstanding students. Queen’s University is an integral part of the vibrant Kingston community in the heart of the Thousand Islands region of southeastern Ontario. It has a community spirit and amenities unmatched by any other Canadian university. The University and the region offer an outstanding academic and community environment (www.queensu.ca).

Kingston Health Sciences Centre is southeastern Ontario’s complex, acute and specialty care, research and teaching hospital. Fully affiliated with Queen’s University, the hospital is ranked as one of Canada’s top research hospitals. As a teaching hospital, KHSC and Queen’s university attracts some of the nation’s brightest learners and researchers contributing to groundbreaking advancements.

Members of the Department of Pathology & Molecular Medicine enjoy competitive compensation and benefits packages. For additional information regarding compensation structures for this position, please contact Dr. Andrea Grin. Academic rank will be commensurate with experience.

Faculty and their dependents are eligible for an extensive benefits package including prescription drug coverage, vision care, dental care, long term disability insurance, life insurance and access to the Employee and Family Assistance Program. Employees also participate in a pension plan. Tuition assistance is available for qualifying employees, their spouses and dependent children. The Department values families and is pleased to provide a ‘top up’ to government parental leave benefits. In addition, Queen’s provides partial reimbursement for eligible daycare expenses for employees with dependent children in daycare. For more information on employee benefits, see Queen’s Human Resources.

How to Apply

The University invites applications from all qualified individuals and is strongly committed to employment equity, diversity, and inclusion in the workplace. Queen’s encourages applications from Black, racialized/visible minority and Indigenous people, women, persons with disabilities, and 2SLGBTQ+ persons. All qualified candidates are encouraged to apply; however, in accordance with Canadian immigration requirements, Canadian citizens and permanent residents will be given priority. Applicants are asked to indicate whether they have valid legal work status in Canada.

The University will provide support throughout the recruitment processes to applicants with disabilities, including accommodation that takes into account an applicant’s accessibility needs. If you require accommodation during the interview process, please contact Lis Andersen Email: la59@queensu.ca

Those interested in this position should submit a complete application package, including the following documents:

a cover letter, summarizing expertise, qualifications, and accomplishments relevant to the position. The cover letter should also indicate whether or not you will require a work permit and/or require support with an extension of your work permit in the future.
a current Curriculum Vitae; and,
the names and full contact information of three referees.

Applications will be reviewed as received and will continue until the position is filled.

Complete applications are to be directed to:

Dr. Andrea Grin, Anatomic Pathology Service Chief & Ms. Lis Andersen, Administrative Manager

Department of Pathology and Molecular Medicine

88 Stuart St.

Richardson Laboratory

Queen's University

Kingston, Ontario K7L 3N6

E-mail: Andrea.Grin@kingstonhsc.ca and Lis.Andersen@kingstonhsc.ca

Departmental website: https://pathology.queensu.ca/

Clinical academic faculty within Queen’s Health Sciences are governed by the Policy for Clinical Academic Faculty Members in the Faculty of Health Sciences.

As part of the application process at Queen’s University, our recruitment process uses Artificial Intelligence (AI), as defined under the Ontario Employment Standards Act, to ask job-related questions and/or assess suitability for hire. All final hiring decisions are made using non-AI related processes.

FLASF Special Awards

Spotlight

| 31 March 2026

2026 Frontenac Lennox and Addington Science Fair (FLASF) Special Award: Department of Pathology and Molecular Medicine

The awards were given for “Best projects related to the body's response to disease or tissue damage”

1st: Maya Thakrar: 2409 Understanding and modelling arterial plaque build up

2nd: Kahvian Omrani: 3401 Neurosense: saliva-based seizure risk prediction

3rd: Mariam Sultan: 2481 Breast cancer awareness

Maya built a physical model using tubing and modeling clay and showed changes in flow rate in response to different levels of vessel obstruction as a model to give more awareness regarding atherosclerosis. As part of her project, she ran multiple trials at different levels of occlusion, and reported the change in flow rate and type of flow of water through her model system. Maya accurately described the development of atherosclerosis and stenosis as well as the early observed developments of plaques in young people.

Kahvian researched epilepsy and biomarkers that would be part of a rapid saliva test to give these patients the ability to predict seizures, allowing them time to get assistance and avoid high risk activities. He researched biomarkers that would best predict the onset of seizures and built a prototype of a possible testing device with the selected biomarkers.

Mariam built a 3D printed model of a breast to provide awareness and training for individuals to do breast self exams. Mariam explained her design process as well as future directions in using training models for self exams. She had a pre- and post-training survey, which she used with a number of volunteers as part of her project. She also educated those visiting the FLASF exhibits to promote breast self exams and general breast cancer awareness.

SEAMO Clinician Scientist Dr. Neil Renwick Receives Provincial Innovation Fund Award

News

| 8 December 2025

Project: Optimizing cancer care delivery through maximally informative molecular diagnostics

SEAMO is celebrating a major milestone with the announcement that Dr. Neil Renwick has been selected by the Innovation Fund Provincial Oversight Committee to receive a 2025 Innovation Fund Award in the Cancer category. This marks the first time a SEAMO project has been recognized at the provincial level, and it highlights the depth of impact our clinician scientists bring to patient care and discovery.

Dr. Renwick’s project focuses on improving the diagnosis and monitoring of neuroendocrine neoplasms (NENs), a group of cancers that often present late because their symptoms are non-specific. His team has discovered a microRNA that is abundant and highly specific to neuroendocrine cells and tumors. This molecular marker has the potential to give pathologists a more accurate diagnostic tool and to support the development of a rapid, sensitive, and inexpensive blood test for patients.

“This work really began with the goal of helping patients with a cancer that is often diagnosed too late,” says Dr. Renwick. “During our research, we identified a microRNA that appears to be present in most neuroendocrine cells and NEN tissues and is more abundant in plasma from individuals with NENs. It brings us a step closer to earlier diagnosis and better access to effective treatment.”

For Dr. Renwick, the award carries personal and professional significance.

“I was a little shocked to receive this award. Once it sank in, I thought about my parents and my wife and how lucky I am to have supportive people in my life. Professionally, I am thrilled because this recognition shines a light on a disease that was described as neglected only a decade ago. It also feels like a meaningful way to thank SEAMO for supporting me with a New Clinician Scientist Award.”

His project’s success reflects the strength of his team and collaborators across Queen’s and the country. Dr. Renwick speaks proudly about the people behind the work, including Research Associate Dr. Xiaojing Yang, biomedical data analyst Dr. Kathrin Tyryshkin, and the many trainees who contributed to the lab’s discoveries. He also credits colleagues in Medicine, Oncology, Surgery, and partner institutions across Canada for helping advance a shared goal of improving patient outcomes. “This type of research really takes a village,” he says.

Dr. Lisa Tannock, SEAMO’s CEO, says this recognition is an exciting moment for the organization. “This is the first time a SEAMO project has received a Provincial Innovation Fund Award, and we could not be more proud of Dr. Renwick and his team. Their work is opening the door to earlier diagnosis and better care for patients across the province. It is a remarkable achievement and a reflection of the innovation and dedication that define SEAMO’s clinician scientists.”

The progress coming from Dr. Renwick’s lab is the result of teamwork, shared purpose, and a deep commitment to improving the lives of people facing complex cancers. SEAMO is proud to support this type of work and the collaborators that make it possible.

Articles

2026 William Corbett Award

ACADEMIC GYNECOLOGIC PATHOLOGIST

FLASF Special Awards

SEAMO Clinician Scientist Dr. Neil Renwick Receives Provincial Innovation Fund Award

Recent Posts